Molecular analysis of dermatophytes suggests spread of infection among household members

Cutis

Volumn 91, Issue 5, 2013, Pages 237-245

  Ghannoum, Mahmoud A ^a   Mukherjee, Pranab K ^a   Warshaw, Erin M ^b   Evans, Scott ^c   Korman, Neil J ^a   Tavakkol, Amir ^d,e  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e Topica Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; DERMATOMYCOSIS; DISEASE TRANSMISSION; EPIDERMOPHYTON; FAMILY SIZE; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; ONYCHOMYCOSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SKIN DISEASE; STATISTICAL MODEL; TINEA PEDIS; TRICHOPHYTON;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; DERMATOMYCOSES; EPIDERMOPHYTON; FAMILY CHARACTERISTICS; FEMALE; FOOT DERMATOSES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ONYCHOMYCOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TINEA PEDIS; TRICHOPHYTON; YOUNG ADULT;

EID: 84882710911     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003;67:101-108.
2. Bell-Syer SE, Hart R, Crawford F, et al. Oral treatments for fungal infections of the skin of the foot [update published in Cochrane Database Syst Rev. 2012;10:CD003584]. Cochrane Database Syst Rev. 2002:CD003584.
3. Elewski BE. Onychomycosis. treatment, quality of life, and economic issues. Am J Clin Dermatol. 2000;1:19-26.
4. Jennings MB, Pollak R, Harkless LB, et al. Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial. J Am Podiatr Med Assoc. 2006;96:465-473.
5. Rupke SJ. Fungal skin disorders. Prim Care. 2000;27:407-421.
6. Hay R. Literature review. onychomycosis. J Eur Acad Dermatol Venereol. 2005;19(suppl 1):1-7.
7. Borgers M, Degreef H, Cauwenbergh G. Fungal infections of the skin: infection process and antimycotic therapy. Curr Drug Targets. 2005;6:849-862.
8. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections [published online ahead of print May 14, 2008]. Mycopathologia. 2008;166:335-352.
9. English MP. Trichophyton rubrum infection in families. Br Med J. 1957;1:744-746.
10. Weitzman I, Kane J. Dermatophytes and agents of superficial mycoses. In: Balows A, Hausler WJ Jr, Herrmann KL, et al, eds. Manual of Clinical Microbiology. 5th ed. Washington, DC: American Society for Microbiology; 1991:601-616.
11. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev. 1995;8:240-259.
12. Ghannoum MA, Hajjeh RA, Scher R, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641-648.
13. Shehata AS, Mukherjee PK, Aboulatta HN, et al. Single-step PCR using (GACA)4 primer: utility for rapid identification of dermatophyte species and strains [published online ahead of print June 25, 2008]. J Clin Microbiol. 2008;46:2641-2645.
14. Jackson CJ, Barton RC, Evans EG. Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions. J Clin Microbiol. 1999;37:931-936.
15. Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem. 1998;273:26078-26086.
16. Mukherjee PK, Seshan KR, Leidich SD, et al. Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo. Microbiology. 2001;147(pt 9):2585-2597.
17. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol. 1996;35:539-542.
18. Perea S, Ramos MJ, Garau M, et al. Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain. J Clin Microbiol. 2000;38:3226-3230.
19. Aly R, Hay RJ, Del Palacio A, et al. Epidemiology of tinea capitis. Med Mycol. 2000;38(suppl 1):183-188.
20. Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol. 2004;50:748-752.
21. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000;42(1, pt 1):1-20; quiz 21-24.
22. Pomeranz AJ, Sabnis SS, McGrath GJ, et al. Asymptomatic dermatophyte carriers in the households of children with tinea capitis. Arch Pediatr Adolesc Med. 1999;153:483-486.
23. Yazdanparast A, Jackson CJ, Barton RC, et al. Molecular strain typing of Trichophyton rubrum indicates multiple strain involvement in onychomycosis. Br J Dermatol. 2003;148:51-54.
24. Gupta AK, Kohli Y, Summerbell RC. Variation in restriction fragment length polymorphisms among serial isolates from patients with Trichophyton rubrum infection. J Clin Microbiol. 2001;39:3260-3266.
25. Roberts DT, Evans EG. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol. 1998;138:189-190.
26. Many H, Derbes VJ, Friedman L. Trichophyton rubrum: exposure and infection within household groups. Arch Dermatol. 1960;82:226-229.
27. Asz-Sigall D, López-García L, Vega-Memije ME, et al. HLA-DR6 association confers increased resistance to T. rubrum onychomycosis in Mexican Mestizos. Int J Dermatol. 2010;49:1406-1409.
28. Zaias N, Tosti A, Rebell G, et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 1996;34(2, pt 1):302-304.
29. Faergemann J, Correia O, Nowicki R, et al. Genetic predisposition-understanding underlying mechanisms of onychomycosis. J Eur Acad Dermatol Venereol. 2005;19 (suppl 1):17-19.